HI HB254

Allows pharmacists to dispense interchangeable biological products approved by the director as substitutes for brand-name biologics, similar to generic drug substitution.

Requires pharmacists to offer consumers interchangeable biological products from the Hawaii list when filling prescriptions and inform them of potential savings.

Mandates pharmacists communicate the specific biological product name and manufacturer to the prescriber within two business days of dispensing.

Repeals the Drug Product Selection Board and transfers its duties to the Director of Health, who will maintain the Hawaii list of equivalent generic drug products and interchangeable biological products.

Effective July 1, 2016.